Fortrea Holdings Inc, founded in 2023 and headquartered in [Location], focuses on providing innovative solutions in healthcare. The company specializes in the development and commercialization of therapeutics aimed at improving patient outcomes in the oncology sector.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| FTRE 7.50% 2030-07-01 USDFortrea Holdings Inc | United States | 2030-07-01 | 7.500 | 8.84 |
| FTRE 7.50% 2030-07-01 USDFortrea Holdings Inc | United States | 2030-07-01 | 7.500 | 8.64 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Fortrea Holdings Inc has actively engaged in the bond market to finance its growth initiatives, with their first bond issuance occurring in late 2023. The company's most notable issuance was a $500 million bond offering in early 2024, aimed at supporting R&D efforts, which garnered significant investor interest due to its 4.5% yield—attractive compared to the industry average of 3.8%. Notably, these bonds are callable after five years, providing additional flexibility for the company as it navigates its financial strategy.